Single-dose depot leuprolide is as efficient as daily short-acting leuprolide in ICSI cycles | Zendy

Mete Işıkoğlu | Zendy; Sadi S. Özdem | Zendy; Murat Berkkanoğlu | Zendy; H. Jamal | Zendy; Z. Senturk | Zendy; Kemal Özgür | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Single-dose depot leuprolide is as efficient as daily short-acting leuprolide in ICSI cycles

Author(s) -

Mete Işıkoğlu,

Sadi S. Özdem,

Murat Berkkanoğlu,

H. Jamal,

Z. Senturk,

Kemal Özgür

Publication year - 2007

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem054

Subject(s) - depot , medicine , controlled ovarian hyperstimulation , leuprorelin , randomized controlled trial , urology , gonadotropin releasing hormone , pregnancy , in vitro fertilisation , luteinizing hormone , hormone , biology , genetics , archaeology , history

In this prospective randomized study, we aimed to compare the efficacy of a single depot (1.88 mg) reduced dose with a daily low dose (0.5 mg/day) of leuprolide for pituitary suppression as part of controlled ovarian hyperstimulation (COH) in an ICSI program.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research